Gastroenterology - European Medical Journal

Continue

Gastroenterology

Filter
14 Dec 2017

Introducing EMJ Gastroenterology 6.1

The European Medical Journal welcomes you to their annual publication of EMJ Gastroenterology…
30 Nov 2017

Protein from a Worm Parasite Could Provide New Treatments for Inflammatory Bowel Diseases

A PROTEIN from a worm parasite could provide the basis for future treatment options for inflammatory bowel diseases, according to researchers at the…
13 Nov 2017

Significant Mortality Benefits of Mechanical Valves

MECHANICAL valves have very good long-term mortality benefits and should be used more often, particularly in younger patients who require mitral-valve…
7 Nov 2017

Genetic Predictors for Oesophageal Cancer Identified in High-Risk Patients

OESOPHAGEAL cancer could be diagnosed up to 8 years before the first symptoms appear, enabling earlier treatment of the condition, according to…
10 Oct 2017

RedHill Biopharma Announces Positive Top-Line Results from Phase II Study of BEKINDA® in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Tel-Aviv, Israel/Raleigh, NC, USA, 03 October, 2017 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“Red Hill” or the “Company”)…
3 Oct 2017

Studying Protein Networks in Bowel Cancer

PROTEOMIC study of bowel cancer cells identifies common protein mutations and allows the prediction of treatment response….
3 Oct 2017

Role of Gut Bacteria as a Parkinson’s Disease Biomarker

BACTERIAL communities in the gut of Parkinson’s patients differ to those of healthy people, potentially providing an early indicator of the…
19 Sep 2017

RedHill Biopharma Initiates Promotion of Esomeprazole Strontium Delayed-Release Capsules 49.3 mg in the U.S.

RedHill Biopharma Ltd. announced that it has initiated promotion of Esomeprazole Strontium Delayed-Release (DR) Capsules 49.3 mg1 in the U.S.
We’ve noticed you’re accessing
from North/South America.